Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00590759 · ClinicalTrials.gov registry record · NA
Evaluation of the GORE TAG Thoracic Endoprosthesis in the Treatment of Aneurysms
A NA study, sponsored by W.L.Gore & Associates.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT00590759: Completed NA study, sponsored by W.L.Gore & Associates.
NCT00590759 is a NA study that has completed, run by W.L.Gore & Associates. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00590759, a NA study, has completed, sponsored by W.L.Gore & Associates.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
The purpose of this post-approval study is to evaluate the long-term performance of the GORE TAG® Thoracic Endoprosthesis (TAG device) in the primary treatment of descending thoracic aortic (DTA) aneurysms
Primary Outcome
Freedom from aneurysm related mortality for TAG 05-02 subjects
Interventions
- DEVICE GORE TAG® Thoracic Endoprosthesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2005-08 |
| Est. Completion | 2013-04 |
| Phase | NA |
What the finished NCT00590759 record still lists
NCT00590759 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which GORE TAG® Thoracic Endoprosthesis is the first listed.
NCT00590759 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00590759 about?
NCT00590759 is a clinical study titled "Evaluation of the GORE TAG Thoracic Endoprosthesis in the Treatment of Aneurysms". The purpose of this post-approval study is to evaluate the long-term performance of the GORE TAG® Thoracic Endoprosthesis (TAG device) in the primary treatment of descending thoracic aortic (DTA) aneurysms
What is the current status of trial NCT00590759?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2005-08. Estimated completion is 2013-04.
What interventions are being tested in trial NCT00590759?
The interventions under investigation include: GORE TAG® Thoracic Endoprosthesis (DEVICE).
Who is sponsoring clinical trial NCT00590759?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00590759's enrollment target sits among peer trials
150 661st of 2000 higher than 1,299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia